Michael D Prados Selected Research

Carmustine (FIVB)

4/2004	Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
1/2004	Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael D Prados Research Topics

Disease

64	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 10/2002
56	Neoplasms (Cancer) 11/2023 - 01/2003
55	Glioma (Gliomas) 01/2022 - 04/2002
31	Brain Neoplasms (Brain Tumor) 01/2021 - 04/2002
5	Fatigue 11/2023 - 10/2009
5	Gliosarcoma 05/2013 - 02/2009
5	Astrocytoma (Pilocytic Astrocytoma) 05/2013 - 10/2002
4	Neutropenia 11/2023 - 08/2006
4	Hypertension (High Blood Pressure) 11/2023 - 10/2009
3	Lymphopenia (Lymphocytopenia) 01/2014 - 08/2005
3	Meningioma (Meningiomas) 01/2010 - 12/2009
3	Exanthema (Rash) 02/2009 - 08/2006
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 10/2009
2	Medulloblastoma 08/2023 - 08/2015
2	Diarrhea 01/2018 - 01/2004
2	Thrombocytopenia (Thrombopenia) 11/2012 - 08/2010
2	Lung Neoplasms (Lung Cancer) 05/2012 - 04/2011
2	Ependymoma 01/2012 - 07/2005
2	Infections 06/2011 - 06/2008
2	Hemorrhage 08/2010 - 08/2006
2	Disease Progression 04/2010 - 10/2005
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2009 - 08/2006
2	Residual Neoplasm 04/2004 - 01/2004
1	Central Nervous System Neoplasms 08/2023
1	Diffuse Intrinsic Pontine Glioma 12/2020

Drug/Important Bio-Agent (IBA)

34	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 10/2002
13	ErbB Receptors (EGF Receptor)IBA 07/2014 - 06/2005
12	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 06/2005
11	EnzymesIBA 06/2012 - 01/2004
11	Anticonvulsants (Antiepileptic Drugs)IBA 06/2012 - 01/2004
7	Bevacizumab (Avastin)FDA Link 11/2023 - 10/2009
7	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 01/2004
6	Tyrosine Kinase InhibitorsIBA 01/2018 - 06/2005
6	Proteins (Proteins, Gene)FDA Link 01/2013 - 07/2003
5	temsirolimus FDA Link 04/2014 - 11/2004
5	epidermal growth factor receptor VIIIIBA 10/2011 - 06/2005
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2010
4	tipifarnib (R115777)IBA 12/2011 - 08/2006
3	VaccinesIBA 01/2022 - 01/2013
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2012
3	cabozantinibIBA 01/2018 - 01/2018
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 12/2012
3	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2015 - 08/2013
3	Sirolimus (Rapamycin)FDA Link 04/2014 - 12/2007
3	Alkylating AgentsIBA 04/2011 - 10/2002
3	Farnesyltranstransferase (Farnesyltransferase)IBA 03/2011 - 08/2006
3	Gefitinib (Iressa)FDA Link 01/2010 - 10/2005
2	dipinacoline glutamateIBA 12/2020 - 03/2014
2	Lipase (Acid Lipase)FDA Link 01/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2018
2	Sorafenib (BAY 43-9006)FDA Link 01/2020 - 12/2012
2	Epidermal Growth Factor (EGF)IBA 01/2020 - 10/2005
2	Alanine Transaminase (SGPT)IBA 01/2018 - 08/2006
2	palbociclibIBA 11/2016 - 04/2010
2	Retinoblastoma ProteinIBA 11/2016 - 01/2012
2	telomerase RNA (bTR)IBA 12/2015 - 07/2014
2	O(6)-Methylguanine-DNA MethyltransferaseIBA 09/2014 - 01/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 07/2011
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014 - 01/2013
2	Peptides (Polypeptides)IBA 01/2014 - 01/2013
2	Mutant Proteins (Protein, Mutant)IBA 05/2013 - 06/2005
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2012 - 08/2010
2	TOR Serine-Threonine KinasesIBA 12/2012 - 12/2009
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2012 - 10/2005
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2012 - 08/2010
2	enzastaurinIBA 12/2011 - 06/2010
2	Sterol Regulatory Element Binding Protein 1IBA 10/2011 - 12/2009
2	Lapatinib (GW572016)FDA Link 10/2011 - 12/2009
2	LuciferasesIBA 04/2011 - 01/2010
2	Angiogenesis InhibitorsIBA 08/2010 - 10/2004
2	Imatinib Mesylate (Gleevec)FDA Link 12/2009 - 08/2006
2	PolylysineIBA 01/2009 - 01/2009
2	Isotretinoin (Accutane)FDA LinkGeneric 01/2009 - 04/2005
2	Poly I-CIBA 01/2009 - 01/2009
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 01/2009 - 01/2009
2	poly ICLCIBA 01/2009 - 01/2009
2	Lomustine (CCNU)FDA Link 08/2008 - 03/2004
2	IL13-PE38IBA 03/2007 - 04/2006
2	Thalidomide (Thalomid)FDA Link 02/2007 - 10/2004
2	Cytotoxins (Cytolysins)IBA 02/2007 - 04/2006
2	Carmustine (FIVB)FDA Link 04/2004 - 01/2004
2	Procarbazine (Matulane)FDA Link 03/2004 - 03/2003
2	Vincristine (Oncovin)FDA LinkGeneric 03/2004 - 03/2003
2	thiamine triphosphorate (TTP)IBA 01/2004 - 01/2003
2	Carboplatin (JM8)FDA LinkGeneric 01/2003 - 04/2002
1	NucleotidesIBA 11/2023
1	Cell-Free Nucleic AcidsIBA 11/2023
1	BRCA1 ProteinIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	tyrosine receptor (receptor, tyrosine)IBA 01/2020
1	NVP-BKM120IBA 01/2019

Therapy/Procedure

32	Therapeutics 08/2023 - 03/2003
20	Radiotherapy 11/2016 - 10/2002
16	Drug Therapy (Chemotherapy) 05/2019 - 01/2003
3	Immunotherapy 12/2020 - 01/2013
3	Craniotomy 02/2012 - 04/2004
2	Drug Tapering 01/2018 - 08/2010
2	Brachytherapy 11/2007 - 04/2004
1	Aftercare (After-Treatment) 05/2019